HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$6.60
Day range
$6.31 - $7.06
Year range
$2.32 - $10.13
Market cap
371.38M USD
Avg Volume
632.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.00M | -30.43% |
Net income | -17.66M | 34.29% |
Net profit margin | — | — |
Earnings per share | -0.28 | 34.88% |
EBITDA | -20.05M | 31.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.60M | 6.23% |
Total assets | 242.65M | 4.33% |
Total liabilities | 14.16M | -25.44% |
Total equity | 228.49M | — |
Shares outstanding | 53.98M | — |
Price to book | 1.56 | — |
Return on assets | -20.27% | — |
Return on capital | -20.89% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.66M | 34.29% |
Cash from operations | -15.26M | 39.66% |
Cash from investing | -777.00K | -102.04% |
Cash from financing | — | — |
Net change in cash | -16.03M | -210.62% |
Free cash flow | -9.28M | 41.12% |
About
Founded
2015
Website
Employees
45
